Advertisement

Ads Placeholder
Loading...

DocMorris AG

DOCM.SWSIX
Healthcare
Medical - Pharmaceuticals
CHF5.01
CHF0.04(0.80%)
Swiss Market opens in NaNh NaNm

DocMorris AG Fundamental Analysis

DocMorris AG (DOCM.SW) shows moderate financial fundamentals with a PE ratio of -1.92, profit margin of -11.95%, and ROE of -30.22%. The company generates $1.1B in annual revenue with strong year-over-year growth of 10.57%.

Key Strengths

Cash Position57.97%
PEG Ratio-0.04
Current Ratio2.19

Areas of Concern

ROE-30.22%
Operating Margin-7.50%
We analyze DOCM.SW's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -5.7/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-5.7/100

We analyze DOCM.SW's fundamental strength across five key dimensions:

Efficiency Score

Weak

DOCM.SW struggles to generate sufficient returns from assets.

ROA > 10%
-16.28%

Valuation Score

Excellent

DOCM.SW trades at attractive valuation levels.

PE < 25
-1.92
PEG Ratio < 2
-0.04

Growth Score

Excellent

DOCM.SW delivers strong and consistent growth momentum.

Revenue Growth > 5%
10.57%
EPS Growth > 10%
35.96%

Financial Health Score

Excellent

DOCM.SW maintains a strong and stable balance sheet.

Debt/Equity < 1
0.71
Current Ratio > 1
2.19

Profitability Score

Weak

DOCM.SW struggles to sustain strong margins.

ROE > 15%
-3022.11%
Net Margin ≥ 15%
-11.95%
Positive Free Cash Flow
No

Key Financial Metrics

Is DOCM.SW Expensive or Cheap?

P/E Ratio

DOCM.SW trades at -1.92 times earnings. This suggests potential undervaluation.

-1.92

PEG Ratio

When adjusting for growth, DOCM.SW's PEG of -0.04 indicates potential undervaluation.

-0.04

Price to Book

The market values DocMorris AG at 0.63 times its book value. This may indicate undervaluation.

0.63

EV/EBITDA

Enterprise value stands at -1.90 times EBITDA. This is generally considered low.

-1.90

How Well Does DOCM.SW Make Money?

Net Profit Margin

For every $100 in sales, DocMorris AG keeps $-11.95 as profit after all expenses.

-11.95%

Operating Margin

Core operations generate -7.50 in profit for every $100 in revenue, before interest and taxes.

-7.50%

ROE

Management delivers $-30.22 in profit for every $100 of shareholder equity.

-30.22%

ROA

DocMorris AG generates $-16.28 in profit for every $100 in assets, demonstrating efficient asset deployment.

-16.28%

Following the Money - Real Cash Generation

Operating Cash Flow

DocMorris AG generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.

$0.00

Free Cash Flow

DocMorris AG generates weak or negative free cash flow of $0.00, restricting financial flexibility.

$0.00

FCF Per Share

Each share generates $0.00 in free cash annually.

$0.00

FCF Yield

DOCM.SW converts 0.00% of its market value into free cash.

0.00%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-1.92

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.04

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.63

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.22

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.71

vs 25 benchmark

Current Ratio

Current assets to current liabilities

2.19

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.30

vs 25 benchmark

ROA

Return on assets percentage

-0.16

vs 25 benchmark

ROCE

Return on capital employed

-0.12

vs 25 benchmark

How DOCM.SW Stacks Against Its Sector Peers

MetricDOCM.SW ValueSector AveragePerformance
P/E Ratio-1.9228.45 Better (Cheaper)
ROE-30.22%763.00% Weak
Net Margin-11.95%-45266.00% (disorted) Weak
Debt/Equity0.710.34 Weak (High Leverage)
Current Ratio2.192795.60 Strong Liquidity
ROA-16.28%-16586.00% (disorted) Weak

DOCM.SW outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews DocMorris AG's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-72.81%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

64.63%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

100.00%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ